Descriptor English: | Timolol | ||||||
Descriptor Spanish: |
Timolol
| ||||||
Descriptor Portuguese: | Timolol | ||||||
Descriptor French: | Timolol | ||||||
Entry term(s): |
(S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)- Blocadren L 714,465 L-714,465 L714,465 MK 950 MK-950 MK950 Optimol Timacar Timolol Hemihydrate Timolol Maleate Timolol Maleate, (1:1) Salt Timoptic Timoptol |
||||||
Tree number(s): |
D02.033.100.624.915 D02.033.755.624.915 D02.092.063.624.915 D02.886.675.867.768 D03.383.129.708.867.768 D03.383.533.640.775 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D013999 | ||||||
Scope note: | A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Adrenergic beta-Antagonists Anti-Arrhythmia Agents Antihypertensive Agents |
||||||
Registry Number: | 817W3C6175 | ||||||
Previous Indexing: |
Amino Alcohols (1972-1973) Morpholines (1972-1975) Propanolamines (1974-1976) Thiadiazoles (1972-1976) |
||||||
Public MeSH Note: | 1984; TIMOLOL was indexed under PROPANOLAMINES 1977-1983 |
||||||
History Note: | 1984 (1977) |
||||||
DeCS ID: | 14386 | ||||||
Unique ID: | D013999 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1984/01/01 | ||||||
Date of Entry: | 1976/04/13 | ||||||
Revision Date: | 2018/06/19 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Timolol
- Preferred
Timolol Maleate
- Narrower
(S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol
- Narrower
Timoptic
- Narrower
Timoptol
- Narrower
Timacar
- Narrower
Timolol Hemihydrate
- Narrower
Blocadren
- Narrower
L-714,465
- Narrower
MK-950
- Narrower
Optimol
- Narrower
Concept UI |
M0021546 |
Scope note | A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. |
Preferred term | Timolol |
Concept UI |
M0021551 |
Preferred term | Timolol Maleate |
Entry term(s) |
Timolol Maleate, (1:1) Salt |
Concept UI |
M000642429 |
Preferred term | (S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol |
Entry term(s) |
2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)- |
Concept UI |
M0021547 |
Preferred term | Timoptic |
Concept UI |
M0021548 |
Preferred term | Timoptol |
Concept UI |
M0021545 |
Preferred term | Timacar |
Concept UI |
M000638570 |
Preferred term | Timolol Hemihydrate |
Concept UI |
M0021544 |
Preferred term | Blocadren |
Concept UI |
M0350584 |
Preferred term | L-714,465 |
Entry term(s) |
L 714,465 L714,465 |
Concept UI |
M0021549 |
Preferred term | MK-950 |
Entry term(s) |
MK 950 MK950 |
Concept UI |
M0021550 |
Preferred term | Optimol |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey